
Latest Medical News, Clinical Trials, Guidelines - Medscape
4 days ago · Today on Medscape : Get the latest medical news, clinical trial coverage, drug updates, journal articles, CME activities & more on Medscape. A free resource for physicians.
Orthopedics - Medscape
Apr 12, 2026 · Orthopedics : Welcome to Medscape Orthopedics, where you can peruse the latest medical news, commentary from clinician experts, major conference coverage, full-text journal …
Medscape Medical News - Index
2 days ago · Antibiotics After GI Infections Raise IBS Risk Use of antibiotics is linked to a higher risk of developing irritable bowel syndrome, especially when antibiotics are taken for gastrointestinal ...
Acute Coronary Syndromes - Medscape
Mar 30, 2026 · Acute Coronary Syndromes : Review in-depth clinical information, latest medical news, and guidelines about acute coronary syndrome, classified as either ST segment elevation myocardial …
Pediatrics Cases & Quizzes - Index - Medscape
Apr 2, 2026 · Rapid Review Quiz: Acute Compartment Syndrome Are you able to recognize and treat acute compartment syndrome? Test your knowledge with this short quiz.
Rifaximin for Irritable Bowel Syndrome? - Medscape
Because patients with irritable bowel syndrome (IBS) can have alterations in bacterial bowel flora, antibiotic therapies have been proposed. To investigate whether antibiotic therapy is effective ...
Carrageenan: Allergen for Patients With Alpha Gal? - Medscape
Mar 16, 2026 · Many people with alpha-gal syndrome may be unaware of the allergenicity of the common food and drug additive.
HFpEF in Primary Care: Best Pharmacotherapy - Medscape
Feb 6, 2025 · The Curbsiders address the primary care management of heart failure with preserved ejection fraction, with tips from esteemed expert Dr Michelle Kittleson.
How to Better Diagnose and Manage Rumination Syndrome - Medscape
Jun 14, 2024 · Recognizing rumination syndrome and understanding its available treatment options are critical in helping patients with this acquired GI disorder that leads to uncomfortable regurgitation.
Fremanezumab for Pediatric Migraine: Phase 3 Results - Medscape
Jan 16, 2026 · The trial is the first phase 3 study to demonstrate a significant reduction in monthly migraine and headache days with fremanezumab for episodic migraine in this patient population.